...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this

KK2 - What is the fully diluted share dilution from 2021 to 2022, 2022 to 2023? Fuzzyjr's smoke & mirrors comment may have a lot of validity.

tada

 

Share
New Message
Please login to post a reply